These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12684407)

  • 21. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.
    Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J
    Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
    Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease family history and modification of breast cancer risk in common BRCA2 variants.
    Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Falcini F; Strada M; Morini N; Naldoni C; Paradiso A; Tommasi S; Schittulli F; Amadori D; Calistri D
    Oncol Rep; 2008 Mar; 19(3):783-6. PubMed ID: 18288416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of interleukin-10 gene variation with breast cancer prognosis.
    Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
    Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of germ-line genetic variation on breast cancer survival in a population-based study.
    Goode EL; Dunning AM; Kuschel B; Healey CS; Day NE; Ponder BA; Easton DF; Pharoah PP
    Cancer Res; 2002 Jun; 62(11):3052-7. PubMed ID: 12036913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.
    Papadopoulou E; Tripsianis G; Anagnostopoulos K; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(2):113-21. PubMed ID: 18237248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
    Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
    Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-repair genetic polymorphisms and breast cancer risk.
    Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.
    Miyoshi Y; Ando A; Egawa C; Taguchi T; Tamaki Y; Tamaki H; Sugiyama H; Noguchi S
    Clin Cancer Res; 2002 May; 8(5):1167-71. PubMed ID: 12006533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.
    Akisik E; Dalay N
    Exp Mol Pathol; 2004 Jun; 76(3):260-3. PubMed ID: 15126109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer.
    van Gils CH; Onland-Moret NC; Roest M; van Noord PA; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1194-9. PubMed ID: 14652280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients.
    Bonafé M; Ceccarelli C; Farabegoli F; Santini D; Taffurelli M; Barbi C; Marzi E; Trapassi C; Storci G; Olivieri F; Franceschi C
    Clin Cancer Res; 2003 Oct; 9(13):4860-4. PubMed ID: 14581358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer.
    Yuan ZQ; Bégin LR; Wong N; Brunet JS; Trifiro M; Gordon PH; Pinsky L; Foulkes WD
    Br J Cancer; 1999 Nov; 81(5):850-4. PubMed ID: 10555757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women.
    Sangrajrang S; Schmezer P; Burkholder I; Waas P; Boffetta P; Brennan P; Bartsch H; Wiangnon S; Popanda O
    Breast Cancer Res Treat; 2008 Sep; 111(2):279-88. PubMed ID: 17922186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
    Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
    Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
    Montgomery KG; Chang JH; Gertig DM; Dite GS; McCredie MR; Giles GG; Southey MC; Hopper JL; Campbell IG
    Breast Cancer Res; 2005; 7(3):R353-6. PubMed ID: 15987430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
    Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
    Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.